The Evidence Base Post 31 January 2024 Trust, transparency, affordability: engaging patients for fair IRA drug pricing Jason Spangler (Innovation and Value Initiative) & Kistein Monkhouse (Patient Orator) Register with The Evidence Base for free to access this content Already have an account? Sign in By registering with The Evidence Base, you will receive our weekly round-up and other relevant editorial content. You can opt-out at any time. View our privacy policy here.